Ticker
LABCompany Name
STANDARD BIOTOOLS INCSector
HealthcareIndustry
Diagnostics & ResearchExchange
NASDAQDate | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -95.89M | -62.17% | $ 154.24M |
3/31/2025 | $ -107.55M | -63.38% | $ 169.69M |
12/31/2024 | $ -112.37M | -64.42% | $ 174.43M |
9/30/2024 | $ -104.99M | -67.34% | $ 155.9M |
6/30/2024 | $ -101.97M | -74.81% | $ 136.3M |
3/31/2024 | $ -76.44M | -60.31% | $ 126.76M |
12/31/2023 | $ -65.66M | -61.74% | $ 106.34M |
9/30/2023 | $ -66.69M | -63.41% | $ 105.17M |
6/30/2023 | $ -76.44M | -72.49% | $ 105.45M |
3/31/2023 | $ -124.87M | -129.31% | $ 96.56M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBITDA / Revenues
(=) EBITDA %
EBITDA % for STANDARD BIOTOOLS INC is calculated as follows: EBITDA [ $ -40.1M ] / Revenues [ $ 125.98M ]
(=) EBITDA % [ -31.83% ]
Minimum
Dec 31, 2022
Maximum
Sep 30, 2020
Average
Median
filtered constituents | 3.29K |
---|---|
min | -74.98% |
max | 97.73% |
average | 16.16% |
median | 14.74% |
std | 26.84% |